- Home
- BOF vs ELUT Comparison
BOF vs ELUT Comparison
Compare BOF & ELUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BOF | ELUT |
|---|---|---|
| Founded | 2017 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Medical Specialities |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.6M | 48.3M |
| IPO Year | 2023 | 2020 |
Fundamental Metrics
Financial Performance| Metric | BOF | ELUT |
|---|---|---|
| Price | $3.19 | $1.12 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 89.9K | ★ 150.9K |
| Earning Date | 05-14-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 31.33 | ★ 146.77 |
| EPS | ★ N/A | N/A |
| Revenue | $3,184,018.00 | ★ $12,293,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $10.83 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 258.20 | N/A |
| 52 Week Low | $1.65 | $0.50 |
| 52 Week High | $4.95 | $2.60 |
Technical Indicators
Market Signals| Indicator | BOF | ELUT |
|---|---|---|
| Relative Strength Index (RSI) | 46.24 | 56.86 |
| Support Level | $3.21 | $1.00 |
| Resistance Level | $3.47 | $1.18 |
| Average True Range (ATR) | 0.26 | 0.09 |
| MACD | -0.02 | 0.02 |
| Stochastic Oscillator | 39.56 | 57.36 |
Price Performance
Historical ComparisonAbout BOF BranchOut Food Inc.
Branchout Food inc is engaged in the development, marketing, sale, and distribution of plant-based, dehydrated fruit and vegetable snacks and powders. Its products are currently manufactured for the company by contract manufacturers based in South America and North America that produce dehydrated fruit and vegetable products for the company using a new proprietary dehydration technology that it licenses from a third party. The Company's customers are located throughout the United States. Its current primary products are BranchOut Snacks, BranchOut Powders, and BranchOut Industrial Ingredients.
About ELUT Elutia Inc.
Elutia Inc develops proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Its products include CanGaroo, designed for implantable electronic devices, and SimpliDerm, used in soft tissue repair, with functions related to implant support and wound management. The company operates in two segments: Women's Health and Cardiovascular. The majority of revenue is derived from the Women's Health segment.